PDF(Pubmed)
Abstract：
Servo-ventilation (SV) was developed for treating central sleep apnea. To date, primarily SV devices manufactured by Philips Respironics and ResMed are used. However, the difference in reaction to sleep-disordered breathing events between bilevel positive airway pressure AutoSV devices from Philips and adaptive SV devices from ResMed in clinical settings is unknown. Herein, we describe a case of central sleep apnea in which sleep-disordered breathing events were successfully controlled and sleepiness, sleep quality, and tolerance of the device were improved by changing from the bilevel positive airway pressure AutoSV device from Philips to the adaptive SV device from ResMed. Changing the SV devices can be a clinical option to appropriately control sleep-disordered breathing events in patients receiving SV therapy who present with persistent sleep-disordered breathing.
Hamada S, Togawa J, Sunadome H, Nagasaki T, Hirai T, Sato S. Good clinical response achieved by changing servo-ventilation devices in a patient with central sleep apnea: a case report. J Clin Sleep Med. 2023;19(8):1557-1561.
Hamada S, Togawa J, Sunadome H, Nagasaki T, Hirai T, Sato S. Good clinical response achieved by changing servo-ventilation devices in a patient with central sleep apnea: a case report. J Clin Sleep Med. 2023;19(8):1557-1561.
摘要：
开发了伺服通气（SV）用于治疗中枢性睡眠呼吸暂停（CSA）。迄今为止，主要使用飞利浦Respironics和ResMed制造的SV设备。然而,飞利浦的双水平气道正压通气(BPAP)AutoSV装置和ResMed的ASV装置在临床应用中对睡眠呼吸紊乱(SDB)事件的反应差异尚不清楚.在这里，我们描述了一个CSA案例，SDB事件成功控制和嗜睡，睡眠质量,通过将飞利浦的BPAPAutoSV设备更改为ResMed的ASV设备，提高了设备的耐受性。改变SV装置可以是临床选择,以适当地控制接受SV治疗且呈现持续性SDB的患者的SDB事件。
